Home › UPDATE 1-U.S. FDA approves NPS drug, in move validating Shire takeover deal
 

Keywords :   


UPDATE 1-U.S. FDA approves NPS drug, in move validating Shire takeover deal

2015-01-24 06:29:54| Biotech - Topix.net

The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc's drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc , which recently agreed to acquire NPS for $5.2 billion. Natpara is designed to treat hypoparathyroidism, a condition in which the body's parathyroid gland does not secrete enough parathyroid hormone .

Tags: update move deal drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
21.05RAAA announces two staff promotions
21.051-800-Flowers To Sell Air Wick-Inspired Flower Bouquets
21.05Water firms ask for bill rises of between 24% and 91%
21.05Standard Nutrition introduces Passel Farms; acquires Cactus Family Farms
21.052024 National feeder and stocker receipts down 6 percent from 2023
21.05XSYS launches nyloflex eco flexo plate series
21.05Self-fed lick tubs for supplementing protein to grazing cattle
21.05Global Luxury Perfume Market Size Projected To Grow By $5.59 Billion from 2024-2028: Technavio
More »